acetylglucosamine has been researched along with Tauopathies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, S; Fushimi, M; Koike, T; Kosugi, Y; Lane, W; Masuda, K; Sun, H; Tawada, M; Tjhen, R; Uchiyama, N | 1 |
| Carlson, GA; Dellovade, TL; Graham, DL; Gray, AJ; Hering, H; Joyce, JA; O'Moore, J; Shearman, MS; Yu, D | 1 |
| Gong, CX; Iqbal, K; Liu, F | 1 |
| Vocadlo, DJ; Yuzwa, SA | 2 |
1 review(s) available for acetylglucosamine and Tauopathies
| Article | Year |
|---|---|
O-GlcNAc modification and the tauopathies: insights from chemical biology.
Topics: Acetylglucosamine; Animals; Brain; Neurofibrillary Tangles; Phosphorylation; tau Proteins; Tauopathies | 2009 |
4 other study(ies) available for acetylglucosamine and Tauopathies
| Article | Year |
|---|---|
Discovery of a Novel and Brain-Penetrant
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Brain; Cell Line; Computer Simulation; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Neuroprotective Agents; Structure-Activity Relationship; Tauopathies | 2021 |
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
Topics: Acetylglucosamine; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Disease Models, Animal; Female; Glycosylation; Male; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Phosphorylation; Pyrans; tau Proteins; Tauopathies; Thiazoles | 2014 |
O-GlcNAcylation: A regulator of tau pathology and neurodegeneration.
Topics: Acetylglucosamine; Alzheimer Disease; Animals; Brain; Glucose; Glycosylation; Humans; Mice; Phosphorylation; tau Proteins; Tauopathies | 2016 |
Production of O-GlcNAc Modified Recombinant Tau in E. coli and Detection of Ser400 O-GlcNAc Tau In Vivo.
Topics: Acetylglucosamine; Animals; Brain; Escherichia coli; Humans; In Vitro Techniques; Mice; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; tau Proteins; Tauopathies | 2017 |